Celgene and Covidien Lead Legg Mason’s $332M Healthcare Stock Portfolio

Wall St. Watchdog reveals information regarding Legg Mason Investment Counsel’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 64 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $332.27 million.

  • Celgene Corporation (NASDAQ:CELG): On 06/30/2011, Legg Mason Investment Counsel reported holding 896,370 shares with a market value of $54,069,038. This comprised 1.32% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 896,021 shares with a market value of $55,472,660. This comprised 1.59% of the total portfolio. The net change in shares for this position over the two quarters is -349. About Company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • Covidien Plc (NYSE:COV): On 06/30/2011, Legg Mason Investment Counsel reported holding 1,246,375 shares with a market value of $66,344,541. This comprised 1.63% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 1,242,700 shares with a market value of $54,803,068. This comprised 1.57% of the total portfolio. The net change in shares for this position over the two quarters is -3,675. About Company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Legg Mason Investment Counsel reported holding 915,117 shares with a market value of $37,894,995. This comprised 0.93% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 961,615 shares with a market value of $37,310,661. This comprised 1.07% of the total portfolio. The net change in shares for this position over the two quarters is 46,498. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Legg Mason Investment Counsel reported holding 507,176 shares with a market value of $33,737,346. This comprised 0.83% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 484,373 shares with a market value of $30,849,716. This comprised 0.89% of the total portfolio. The net change in shares for this position over the two quarters is -22,803. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Legg Mason Investment Counsel reported holding 691,975 shares with a market value of $24,419,798. This comprised 0.6% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 728,970 shares with a market value of $23,837,320. This comprised 0.68% of the total portfolio. The net change in shares for this position over the two quarters is 36,995. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Legg Mason Investment Counsel reported holding 451,288 shares with a market value of $29,058,434. This comprised 0.71% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 419,672 shares with a market value of $21,252,190. This comprised 0.61% of the total portfolio. The net change in shares for this position over the two quarters is -31,616. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Legg Mason Investment Counsel reported holding 323,106 shares with a market value of $17,001,837. This comprised 0.42% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 321,679 shares with a market value of $16,450,664. This comprised 0.47% of the total portfolio. The net change in shares for this position over the two quarters is -1,427. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Becton Dickinson And Company (NYSE:BDX): On 06/30/2011, Legg Mason Investment Counsel reported holding 204,447 shares with a market value of $17,617,198. This comprised 0.43% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 186,610 shares with a market value of $13,682,245. This comprised 0.39% of the total portfolio. The net change in shares for this position over the two quarters is -17,837. About Company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Legg Mason Investment Counsel reported holding 257,669 shares with a market value of $7,462,094. This comprised 0.18% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 252,577 shares with a market value of $7,925,866. This comprised 0.23% of the total portfolio. The net change in shares for this position over the two quarters is -5,092. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Legg Mason Investment Counsel reported holding 437,765 shares with a market value of $9,017,959. This comprised 0.22% of the total portfolio. On 09/30/2011, Legg Mason Investment Counsel reported holding 397,146 shares with a market value of $7,021,541. This comprised 0.2% of the total portfolio. The net change in shares for this position over the two quarters is -40,619. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

(Note: Data regarding Legg Mason Investment Counsel’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet